Company Profile

Cambridge Polymer Group Inc (AKA: CPG)
Profile last edited on: 4/28/2020      CAGE: 1QKQ7      UEI: DKJDB8BKRGB3

Business Identifier: Analytical instruments and materials used in various industries to include life sciences
Year Founded
1996
First Award
1996
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

56 Roland Street Suite 310
Boston, MA 02129
   (617) 629-4400
   info@campoly.com
   www.campoly.com
Location: Single
Congr. District: 07
County: Suffolk

Public Profile

Cambridge Polymer Group is an ISO 17025-accredited contract research organization specializing in polymer science. Offering a range of services, from routine analytical testing to custom formulation development, the firm's multidiscipline staff is proficient at designing new test methods and instrumentation, and at solving device problems. CPG can function as an out-sourced R&D innovation center, developing proof-of-concept materials, test methods, instruments, and devices based on client specifications or needs. Also providing services in the area of medical device cleanliness, a growing topic in the medical device community, the firm heads up a task force at ASTM focused on drafting standards around device cleanliness. and has the in-house capabilites to perform tests to assess device cleanliness, and assist clients in design considerations for minimizing cleaning issues. Certified to ISO 9001:2015, accredited to ISO 17025:2005, DEA-licensed, and FDA registered, the Cambridge Polymer Group has developed several formulations of ultra high molecular weight polyethylene (UHMWPE) for hip, knee and shoulder applications. These technologies have been approved for use by the FDA in several medical implants, and are available for license.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
20-24
Revenue Range
2M-2.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
50-74

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $1,916,613
Project Title: Preventing Pneumothorax During Transthoracic Lung Biopsy
2021 2 NIH $816,851
Project Title: Degradable Hydrogel For Retinal Tamponade
2009 1 NIH $76,738
Project Title: An Injectable Biocompatible Hydrogel Nucleus Pulposus Replacement
2009 1 NIH $98,285
Project Title: Injectable, Biocompatible Poly (Vinyl Alcohol) Hydrogels For Tissue Bulking
2009 1 DOC $89,526
Project Title: A Fully Integrated Commercial Multi-sample Multi-Slit Rheometer

Key People / Management

  Stephen H Spiegelberg -- President

  Gavin J Braithwaite -- Vice President of Research

  Jeffrey W Ruberti

Company News

There are no news available.